Introducing the Post-Pandemic Change With Lung Cancer Screening

Now Viewing

EP: 1.Introducing the Post-Pandemic Change With Lung Cancer Screening

EP: 2.Opportunities and Challenges With Lung Cancer Screening Following COVID-19

EP: 3.How to Reduce Lung Cancer Screening Disparities After COVID-19

EP: 4.The Effects of COVID-19 and Vaccinations in Non–Small Cell Lung Cancer

EP: 5.Therapeutic Approaches in Small Cell Lung Cancer

EP: 6.2021 USPSTF Lung Cancer Screening Recommendations

EP: 7.Concluding Remarks in Lung Cancer Screening Following COVID-19

Albert Rizzo, MD, FCCP FACP FAASM, chief medical officer of the American Lung Association, as well as clinical assistant professor of medicine at Sidney Kimmel Medical College, Thomas Jefferson University, moderates the webinar Lung Cancer Screening & Treatment After COVID-19.

In this segment, Rizzo introduces the 6 faculty participating in the expert panel, and highlights the topics of discussion, as well as the significance of reviewing lung cancer screening and treatment status amid the COVID-19 pandemic.

The panel features the following experts:

• Albert Rizzo, MD, FCCP FACP FAASM, chief medical officer of the American Lung Association, as well as clinical assistant professor of medicine at Sidney Kimmel Medical College, Thomas Jefferson University
• James L. Mulshine, MD, professor of internal medicine, as well as associate director of the Institute of Translation Medicine at Rush University
• Andrea Borondy Kitts, Lung Cancer and Patient Advocate at Rescue Lung Society
• Sandip Patel, MD, an associate professor of medical oncology at University of California San Diego
• Jacob Sands, MD, a physician at Dana-Farber Cancer Institute, as well as instructor of medicine at Harvard Medical School
• M. Patricia Rivera, MD, professor of medicine at the University of North Carolina at Chapel Hill